Bob Valamehr
Institution Name:
Total Awards:
2
Award Value:
$11,934,448
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Fate Therapeutics, Inc. | A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus | $7,934,448 |
| Late Stage Preclinical Projects | Fate Therapeutics, Inc. | IND enabling development of FT516: A Natural Killer Cell Immunotherapy for Cancer Derived from a Human Inducible Pluripotent Stem Cell | $4,000,000 |
| Total: $11,934,448.00 |